Advertisement
Screener

SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) Operating Lease, Expense

2.8 / 5 stars · 68/120 Roast Me

SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Operating Lease, Expense

SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Operating Lease, Expense of $70.17 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-15.

Discontinued › Expense Statement › Operating Expenses

us-gaap:OperatingLeaseExpense · last filed 2023-03-15

  • SHUTTLE PHARMACEUTICALS HOLDINGS, INC. operating lease, expense for the quarter ending 2022-12-31 was $17.54K, a 18.71% decline year-over-year.
  • SHUTTLE PHARMACEUTICALS HOLDINGS, INC. operating lease, expense for the quarter ending 2021-12-31 was $21.58K.
  • SHUTTLE PHARMACEUTICALS HOLDINGS, INC. operating lease, expense for fiscal 2022 was $70.17K, a 5.20% decline from fiscal 2021.
  • SHUTTLE PHARMACEUTICALS HOLDINGS, INC. operating lease, expense for fiscal 2021 was $74.03K.
Period endOperating Lease, Expense 3 monthOperating Lease, Expense 9 monthOperating Lease, Expense 12 month
2022-12-31$17.54K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15
$70.17K
10-K · filed 2023-03-15
2022-09-30$52.63K
10-Q · filed 2022-11-14
2021-12-31$21.58K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15
$74.03K
10-K · filed 2023-03-15
2021-09-30$52.45K
10-Q · filed 2022-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Rocket One Inc. (RKTO)United States$0.019B
Cellectar Biosciences, Inc. (CLRB)United States$0.020B-1.03
Marker Therapeutics, Inc. (MRKR)United States$0.020B-2.86
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Lipocine Inc. (LPCN)United States$0.017B-1.79
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81